does tirzepatide reduce inflammation in the body How Inflammation? GLP-1 Medications for Weight Loss:

Semaglutide is a GLP-1 receptor agonist , which means it works with hormone pathways involved in appetite, fullness, digestion, and blood sugar response

These dates are backed by extensive stability studies conducted by Novo Nordisk, the manufacturer

Current status: TRIUMPH-4 results available: December 2025 readout showing 28.7% weight loss at 68 weeks (Giblin et al., PMID 41090431) Additional TRIUMPH trials: Expected to report results through 2026, including TRIUMPH-Outcomes (cardiovascular endpoints, NCT06383390, completion Feb 2029) NDA submission timing: Eli Lilly must compile the full trial package before submitting

Nevertheless, medications arent the only way to raise GLP-1 levels